ArticleBMC infectious diseases2026
Trends of antimicrobial resistance in bloodstream infections at a large traditional Chinese medicine hospital in China: a 10-year surveillance study (2015-2024).
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThis study aimed to explore the distribution and antimicrobial resistance of bloodstream infections (BSIs) pathogens at a large traditional Chinese medicine hospital in China.
methodsRetrospective analysis of the pathogen distribution of BSIs and the changes in antimicrobial resistance during a 10-year period (2015-2024) was conducted in Longhua Hospital. Isolate identification was carried out by VITEK
resultsThe most common Gram-negative and Gram-positive BSI-causing bacteria were Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), respectively. The isolation rate of E. coli dropped sharply from 37.33% in 2015-2016 to 15.37% in 2023-2024 (P < 0.01). E. coli displayed the highest sensitivity rates to imipenem, meropenem, and amikacin, with sensitivity rates exceeding 90.00%. The dramatic decreasing trends were observed for Klebsiella pneumoniae (K. pneumoniae) resistance to piperacillin/tazobactam (TZP), cephalosporins, imipenem, meropenem, tobramycin, and levofloxacin. S. aureus had a relatively high resistance rate to penicillin G, and the resistance rate of S. aureus to levofloxacin and moxifloxacin appeared to be rising. The isolation rate of methicillin-resistant S. aureus (MRSA) ranged from 25.00% to 40.00%. Kaplan-Meier survival analysis showed that Acinetobacter baumannii (A. baumannii) infection was associated with a higher 30-day mortality than other infections.
conclusionsThe isolation rate of E. coli exhibited a striking decreasing trend in our retrospective study. The resistance rate of K. pneumoniae to TZP, cephalosporins, imipenem, meropenem, tobramycin, and levofloxacin decreased significantly. The resistance rate of E. coli to carbapenems remained low, and the isolation rate of MRSA was relatively stable during the 10 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.